Syncope in a transsexual male

Journal of Andrology

Volumn 27, Issue 2, 2006, Pages 164-

  Lee, Christine ^a   Basaria, Shehzad ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; DRUG MEGADOSE; ESTROGEN THERAPY; FEMINIZATION; HUMAN; LUNG EMBOLISM; MALE; PRIORITY JOURNAL; SYNCOPE; TRANSSEXUALISM;

ADULT; ESTROGENS; HUMANS; MALE; PULMONARY EMBOLISM; SYNCOPE; TRANSSEXUALISM;

EID: 33644548370     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: 10.2164/jandrol.05088     Document Type: Article

References (6)

1. Asscheman H, Gooren LJG, Eklund PLE. Mortality and morbidity in transsexual patients with cross-gender hormone treatment. Metabolism. 1989;38:869-873.
2. Grodstein F, Stampfer MJ, Goldhaber SZ, Manson JE, Colditz GA, Speizer FE, Willett WC, Hennekens, CH. Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet. 1996;348:983-987.
3. Rosing J, Tans G, Nicolaes GA, Thomassen MC, van Oerle R, van der Ploeg PM, Heijnen P, Hamulyak K, Hemker HC. Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives. Br J Haematol. 1997;97:233-238.
4. The Coronary Drug Project Research Group. The coronary drug project: initial findings leading to modifications of its research protocol. J Am Med Assoc. 1970;214(7):1303-1313.
5. Toorians AWFT, Thomassen MCLGD, Zweegman S, Magdeleyns EJP, Tans G, Gooren LJG, Rosing J. Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people. J Clin Endocrinol Metab. 2003;88:5723-5729.
6. van Kesteren PJM, Asscheman H, Megens JAJ, Gooren LJG. Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin Endocrinol. 1997;47:337-342.